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Abstract
Background: The continuously increasing survivorship of female breast cancer makes the monitoring and improvement
of patients’ quality of life ever so important. While globally there is a growing body of research on health-related quality
of life 1 year after surgical treatment for non-metastatic breast cancer, up-to-date information regarding Greek patients is
scarce.
Objective: To measure the level of QoL of non-metastatic BC survivors in Greece 1 year after surgery.
Methods: A sample of 200 female breast cancer survivors aged 18 to 75, who followed up as outpatients in five public
hospitals were included in this cross-sectional study. All recruited patients agreed to participate in the study (100%
response rate). Quality of life data were collected through the EORTC QLQ-C30 as well as BR23 questionnaires.
Results: Cronbach’s alpha for all scales of the two questionnaires was from 0.551 to 0.936 indicating very good reliability.
According to the Multiple Linear Regression, older patients showed a lower future perspective (p = .031), with those living
in rural areas, which was associated with more financial difficulties (p = .001). Women with tertiary education and those
who had been hospitalized in a university hospital recorded better on global health status (p = .003 and .000 respectively).
Patients who underwent chemotherapy reported better scores in the emotional function sub-scale (p = .025). Women
with reconstruction and at least one complication appeared to have significantly better scores in future perspective and
social function (p = .005, .002 respectively).
Conclusions: Breast cancer survivors were found to have an overall good quality of life, functioning/symptoms scores
and were satisfied with the provided care.
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Background
BC (breast cancer) has a high incidence, with approxi-
mately 5000 new cases reported each year in Greece and
1.67 million cases reported worldwide [1]. Because of
the advances of systemic therapies, the widely used
screening programs, and the high incidence of BC, the
number of BC survivors is continuously increasing [2].
However, despite their benefits these therapies have
numerous side effects, which adversely affect patients’
quality of life (QoL). Cardiovascular complications,
infections, implant removal in patients with implant
reconstruction, higher adjusted total cost and complication-
related cost compose some of the most important complica-
tions and side effects of the treatments [3–5].
The assessment of the health-related quality of life
(HRQoL) is a reliable tool which measures the degree to
which a chronic disease or condition and its treatment
can affect patients’ QoL. It provides healthcare profes-
sionals with data about health status and highlights
problems that are difficult to be recognized during daily
care or consultation [6]. The dimensions that compose
QoL include physical, emotional, social, cognitive, and
sexual function [7]. Even after 5 years of treatment, QoL
continues to impair a large proportion of patients. Long-
term problems include cognitive function, sleep disor-
ders, sexual issues, hot flashes, pain, fatigue, and poly-
neuropathy [8].
These QoL problems should not be underestimated,
because they are prognostic factors for further serious
problems. More specifically, depression and physical dis-
ability are associated with suicidal ideation of BC survi-
vors [9]. Moreover, the frequency of psychological
disorders is correlated with sexual ones, which means
that the BC survivors are experiencing a vicious circle of
problems, where one problem gives positive feedback to
the other [10].
Regarding cognitive impairment, including the domains
of memory, speed of processing, and concentration, BC
survivors reported this impairment as detrimental to their
self-confidence and social relationships [11]. Also, survi-
vors that are functionally deteriorated are more likely to
experience adverse economic situations, such as changes
in earnings, delayed work return, and problems with in-
surance coverage [12]. Undoubtedly, in BC treatment, the
patients’ survival is the clinicians’ first and most important
goal. However, the disease and its treatments have some
side effects that affect negatively BC survivors’ life; the pa-
tient’s QoL, which is often overlooked, is impaired.
Theoretical framework
The present study, guided by the conceptual framework
proposed by Ware [13] and Fayers et al. [14], proposed
four concepts of QoL that must be explored during the
studies of cancer and other diseases. The concepts
consist of personal functioning, psychological distress/
well-being, general health perceptions, and social/role
functioning. Personal functioning is defined as the per-
formance of tasks or the capacity to perform tasks that
most people do daily, including self-care, mobility, and
physical activities. The psychological distress/well-being is
referred to as a personal mental health status. General
health perceptions constitute a self-rating of health, which
encompasses patients’ evaluation of personal health ac-
cording to the three preceding concepts (disease status,
personal functioning, and mental health). The role refers
to the patients’ performance or the capacity to perform ac-
tivities associated with patients’ usual role, including em-
ployment or homemaking and it reflects both on a
person’s health status and the demands of that person’s
chosen role activity. However, the effect of the disease’s
symptoms should also be measured, as they can affect pa-
tients’ QoL [13]. According to Fayers, disease symptoms
such as vomiting, pain, and diarrhea, called causal indica-
tors, can cause impairment of QoL [14].
There is evidence that 1 year after surgical treatment
for non-metastatic BC, HRQoL shows significant im-
provement [15, 16]. In Greece, there are only a few stud-
ies regarding the HRQoL on BC survivors [17, 18]. More
particularly, the first study was limited to stage II BC pa-
tients, while the second study included women who were
still undergoing treatment. The present study had the
largest BC Greek sample compared to previous studies
in Greece and attempts to investigate the potential ef-
fects of variables that haven’t been studied yet (resi-
dence, type of hospital, complications).
Thus, the study had two aims: (a) to explore the effects
of cancer treatments on the QoL of non-metastatic BC
survivors in Greece 1 year after surgery and (b) to inves-
tigate the association of treatment-related side effects




The study protocol was approved by the Ethics Committee
of the “Hippocratio” General Hospital of Athens (reference
number 15564/ 29.8.2014) and then it was approved by the
Ethical Committees of the participant hospitals.
This cross-sectional descriptive study was conducted
from December 1st, 2014 to January 31st, 2017 and was
implemented in five high volume public hospitals in
three distinct regions in Greece, in order to include pa-
tients from rural, urban, and the Athens metropolitan
area (AMA). It is worth noting that the AMA is a heavily
urbanized area with high quality medical services. For
this reason, the variable “place of residence” includes
three categories (rural areas, urban areas, AMA), so as
to receive useful information about the inequalities in
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meeting survivors’ needs and the provision of quality
health services.
Participants
A convenience sample of 200 Greek BC survivors, who
had undergone surgery the year before, had completed
BC treatments (except hormonal therapy) and had
already returned to their daily routine, was constructed
in order to participate in the study. We opted for pa-
tients who had undergone surgery a year ago so that
they would have completed their treatments and
returned to their daily routine. The participants were
followed-up as outpatients during their routine visits to
the surgery clinic, where the researchers contacted them
and collected their demographic data 1 day before their
surgery. Inclusion criteria for the participants were de-
fined as: i) age 18 to 75, ii) ability to understand, con-
sent, and complete the questionnaire, iii) surgical
treatment for BC approximately 1 year earlier, iv) outpa-
tients in public hospitals. Exclusion criteria were: i) his-
tory of other malignancies, ii) metastatic cancer, iii)
inability to communicate in Greek, iv) incomplete BC
treatment. All recruited women consented to participate
in the study (100% response rate).
The participants’ mean age was 56.2 years (SD = 12.6).
There were 36 (18%) patients who underwent breast-
conserving surgery, 97 (48.5%) women who underwent
mastectomy without reconstruction and 67 (33.5%) with
reconstruction. Within the sample, 77% of the patients
underwent chemotherapy, 65% received hormonal ther-
apy and 44.5% radiotherapy. Most of the women had ax-
illary node clearance (78%). Complications appeared in
3.5% of the sample (Table 1).
Instruments
The Greek version of the EORTC-QLQ-C30 and BR23
questionnaires was used [19, 20]. The QLQ-C30 ques-
tionnaire consists of 30 items and assesses the QoL of
patients. It is a general questionnaire that is not specific
for BC and includes five functional scales, physical, cog-
nitive, emotional, social function and role. It also con-
sists of symptom scales (fatigue, nausea and vomiting,
pain, dyspnea, insomnia, appetite loss, constipation, diar-
rhea, and financial difficulty) and global health status /
QoL scales (GHS). Most questions are answered on a 4-
point Likert scale (not at all to very much) and partici-
pants could rate each question on a scale of 0 to 100.
Higher scores for a functional scale indicate a high/
healthy level of functioning, a higher score for the GHS
indicates a high QoL and a higher score for a symptom
scale/items represents a high level of symptomatology/
problems [21].
The QLQ-BR23 questionnaire consists of 23 items and
assesses the QoL of BC patients. It is designed specifically
for BC and includes four functional scales: body image,
sexual functioning, sexual enjoyment, and future perspec-
tive and a “symptom” scale that describes the side effects
of the treatment, breast and arm symptoms and hair loss.
All items were rated on a 4-point Likert scale (not at all to
very much). The scoring approach for the QLQ-BR23 is
identical to the principle we used for the function and
symptom scales/single items of the QLQ-C30 [22].
The demographic and clinical characteristics of the
participants, which included the age, the place of resi-
dence, the educational level, the type of hospital, the
Table 1 Demographic and clinical characteristics of the study
participants (N = 200)
Ν N %
Residence
Athens Metropolitan Area 46 25.7%
Urban center 78 43.6%




High school 62 31.0%
Tertiary 35 17.5%
No education 20 10.0%
Type of hospital
General Hospital 103 51.5%
University Hospital 97 48.5%
Type of surgery
Breast conserving surgery 36 18.0%
Mastectomy without reconstruction 97 48.5%
Mastectomy and reconstruction 67 33.5%
Type of axillary therapy
Sentinel lymph node biopsy 44 22.0%
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type of therapy and the complications were also
collected.
Statistical methods
For the descriptive statistical analysis, continuous variables
were expressed as mean and standard deviation (SD),
while the discrete variables were expressed as frequency
and relative frequency (%). The internal consistency coeffi-
cient was studied using the Cronbach’s Alpha coefficient
of the two questionnaire scales with at least 2 items to
measure the reliability. Values greater than or closer to 0.7
are considered acceptable. Values between 0.5 and 0.6 are
considered sufficient in the initial stages of a study. If the
alpha value exceeds 80%, then it is considered a particu-
larly reliable analysis.
Multiple linear regression was used to investigate the
relationship between the sub-scales of the two question-
naires with demographic factors. The Forward method,
which is used in exploratory studies where there is no
prior knowledge of the independent variables that affect
the dependent variables, was applied to investigate the
independent variables. Statistical analysis of the data was
performed using SPSS-25 statistical software. The mini-
mum value of the level of statistical significance, p-value,
in all statistical tests was set at 0.05.
Results
According to the baseline statistics of the two question-
naires (Table 2), the overall composite score of QLQ-
C30 functional scales indicated a fairly good QoL with
low-intensity symptomatology. A moderate degree of pa-
tient functionality and fewer symptoms were reported in
the QLQ-BR23. Cronbach’s alpha coefficient showed
that the questionnaires were overall considered to be of
high quality in terms of reliability. The only exception
was observed in the physical function sub-scale (0.551).
Multiple linear regression analysis was used to investigate
the relationship between the sub-scales of the two question-
naires with independent factors (Table 3). According to our
findings, the variable “age” was an independent factor for
future perspective, breast/arm symptoms and pain, with
older patients having a lower future perspective, less breast/
arm symptoms and pain. Furthermore, the variable “resi-
dence” showed that women with BC who lived in rural
places had more financial difficulties and a low score on
body image compared to women who lived urban areas
and the AMA. On the contrary, urban women appear to
score better on emotional function, they do not have severe
insomnia problems, and experience fewer systemic therapy
side-effects compared to women of the other two groups.
High scores on the subscale of pain, diarrhea, and breast/
arm morbidity were statistically significant in women resid-
ing in the AMA, who scored low on cognitive as well.
As far as the education level is concerned, a statisti-
cally significant relationship between education and
functional scales/symptoms was revealed. Women with
no education scored low on physical/cognitive function
and had more arm symptoms. Additionally, patients with
secondary (9 years) school educational level appeared to
have a better future perspective, while they lacked
emotional and body image and those with high school
(12 years) education have a significantly lower score on
social. Finally better GHS was reported to women with
tertiary education. Regarding the type of surgery, pa-
tients who underwent mastectomy without reconstruc-
tion demonstrated higher levels of cognitive and social,
but lower levels of role, GHS, sexual function and sexual
enjoyment. On the other hand, women with reconstruc-
tion have significantly better scores in future perspective,
but they lack in body image. In the sub-group “axillary
therapy”, women who underwent sentinel lymph node
biopsy showed less fatigue, dyspnea, diarrhea, and arm
symptoms compared to women with axillary node
clearance.
The adjuvant treatments were identified as statistically
significant independent variables in QoL, as those who
received hormone and chemotherapy recorded better
GHS compared to women who did not receive hormone
therapy and chemotherapy, while those who received
radiotherapy had low scores on emotional, more pain,
appetite loss and constipation compared to patients who
did not receive radiotherapy. Additionally, women who
received hormone therapy scored high in the subscale
“diarrhea” and those who did chemotherapy scored bet-
ter in the emotional sub-scale, but worse in arm symp-
toms. The independent variable “complications” was
considered statistically significant in the subscales of so-
cial function and breast symptoms. Women who re-
ported at least one complication had better social
function and fewer breast symptoms and a lower score
in body image. Finally, patients who had been hospital-
ized in a university hospital rated better on GHS and so-
cial function and experienced fewer diarrheas, but they
lacked body image, compared to those who had been
hospitalized in general hospitals.
Discussion
According to the literature, hair loss is one of the most
important side effects of chemotherapy [23]. Monfared
et al. [24], in their study, found that QoL was lower in
the emotional area compared to other areas. However,
in our study, sample sub-scales GHS and emotional ap-
peared to be improved in patients undergoing chemother-
apy, giving a different perspective for the chemotherapy’s
negative effects. This can probably be explained by the
sense of security that patients have when there is a strong
social support network (more common in non-urban
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communities), as we found a statistical correlation be-
tween rural patients and higher scores in emotional. This
sense of security can also be enhanced by a specialist’s
support. This is consistent with a study that showed that
participation in social support groups can mitigate the ad-
verse psychological effects of BC treatment [25].
The most common type of social support and education
for BC patients is support groups [26]. Professional sup-
port and training are provided by oncology nurses and
other health workers such as psychologists, psychiatrists,
psychotherapists, social workers, physiotherapists [26].
Phone support is a viable option for those who cannot at-
tend support groups or live in rural areas with limited ac-
cess to cancer support services [27]. Besides, symptoms
such as fatigue and nausea from BC treatment can prevent
women from participating in support groups and educa-
tional meetings. Grunfeld and colleagues [28] concluded
that the average cost per patient was lower in telephone
than in hospital follow-up. According to previous studies,
face to face interventions could be a realistic alternative to
conventional cancer care. These programs through indi-
vidual psychosocial support and psychological interven-
tion are beneficial for BC patients and have a positive
effect on their QoL [29].
Regarding the QLQ-BR23 questionnaire, all investigated
symptoms were at fairly favorable levels in our study. The
highest-scoring (worse) symptoms/items were fatigue,
followed by insomnia and financial problems. Our results
strengthen findings from previous studies that also report
significant problems including fatigue, pain in the joints
and sleeping disturbances [12, 30]. Patients living in rural
areas faced more financial difficulties, compared to women
in urban cities and the AMA. Economic difficulties are
negatively correlated with QoL and as the functional status
Table 2 Statistical indicators of the scores of all subscales of the “QLQ-C30/BR23” questionnaires
Scales and sub-scales Items Mean SD Cronbach’s Alpha
EORTC - QLQ-C30
Physical Function 5 81.2 16.5 0.551
Role Function 2 71.0 25.8 0.848
Emotional Function 4 70.0 27.0 0.851
Cognitive Function 2 86.3 19.7 0.704
Social Function 2 80.7 25.0 0.824
Overall composite score (functional scales) 77.8 16.3
Global Health Status 2 55.4 25.0 0.936
Fatigue 3 34.1 23.6 0.855
Nausea and Vomiting 2 8.3 19.4 0.905
Pain 2 20.9 22.5 0.829
Dyspnea 21.4 26.1
Insomnia 26.9 31.8
Appetite Loss 13.2 25.9
Constipation 15.2 26.9
Diarrhea 5.9 17.5
Financial Difficulties 24.3 32.5
Overall composite score (symptom scales) 19.0 17.7
EORTC - QLQ-BR23
Body Image 4 73.7 28.8 0.892
Sexual Function 2 18.6 24.0 0.896
Sexual Enjoyment 43.8 20.6
Future Perspective 56.1 34.7
Overall composite score (functional scales) 48.0 12.2
Systemic Therapy Side-Effects 7 24.5 20.5 0.819
Breast Symptoms 4 13.6 20.7 0.872
Arm Symptoms 3 16.1 19.5 0 .812
Upset by Hair Loss 35.3 25.5
Overall composite score (symptom scales) 22.4 14.6
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Table 3 Summary of Multiple Linear Regression analysis for independent variables predicting sub-scales scores of “QLQ-C30/BR23”
questionnaires
Unstandardized Coefficients R2 (%)
B Std. Error t Sig.
Global Health Status 37.3
(Constant) −8.897 6.750 −1.318 .189
University Hospital 25.483 4.445 5.733 .000
Mastectomy without reconstruction −12.415 3.223 −3.852 .000
Tertiary education −13.005 4.385 −2.966 .003
Hormonal Therapy 7.742 3.146 2.461 .015
Chemotherapy 9.103 3.603 2.526 .012
Physical function 5.9
(Constant) 82.505 1.266 65.150 .000
No education −16.351 4.686 −3.489 .001
Role function 6.3
(Constant) 76.382 2.275 33.572 .000
Mastectomy and reconstruction −14.235 3.952 −3.602 .000
Emotional function 7.1
(Constant) 66.408 9.156 7.253 .000
Radiotherapy −7.687 4.006 −1.919 .057
Urban center 9.756 4.056 2.405 .017
Chemotherapy 10.683 4.727 2.260 .025
Secondary school −12.648 6.323 −2.000 .047
Cognitive function 7.7
(Constant) 86.346 2.492 34.648 .000
Athens Metropolitan Area −7.729 3.535 −2.186 .030
No education −15.512 5.636 −2.752 .007
Mastectomy without reconstruction 6.596 3.121 2.113 .036
Social function 10.3
(Constant) 16.910 18.818 .899 .370
Mastectomy without reconstruction 12.125 3.426 3.540 .001
Complications 29.805 9.491 3.140 .002
Fatigue 1.8
(Constant) 47.681 7.293 6.538 .000
Sentinel Lymph Node Biopsy −8.160 3.999 −2.041 .043
Pain 11
(Constant) 26.459 9.123 2.900 .004
Age −.388 .130 −2.988 .003
Radiotherapy 8.662 3.228 2.683 .008
Athens Metropolitan Area 9.479 3.728 2.542 .012
Dyspnea 2.7
(Constant) 40.054 8.160 4.909 .000
Sentinel Lymph Node Biopsy −10.887 4.474 −2.433 .016
Insomnia 2.4
(Constant) 30.893 3.069 10.066 .000
Urban center −10.807 4.636 −2.331 .021
Yfantis et al. BMC Surgery          (2020) 20:210 Page 6 of 11
Table 3 Summary of Multiple Linear Regression analysis for independent variables predicting sub-scales scores of “QLQ-C30/BR23”
questionnaires (Continued)
Unstandardized Coefficients R2 (%)
B Std. Error t Sig.
Appetite loss 5.9
(Constant) −7.786 5.691 −1.368 .173
Radiotherapy 12.060 3.473 3.473 .001
Constipation 17.1
(Constant) −4.220 6.180 −.683 .496
Athens Metropolitan Area 24.521 4.235 5.790 .000
Radiotherapy 8.378 3.710 2.258 .025
Diarrhea 7.5
(Constant) 16.586 7.164 2.315 .022
Hormonal therapy 6.849 2.528 2.709 .007
University Hospital −5.744 2.378 −2.415 .017
Sentinel Lymph Node Biopsy −6.763 2.865 −2.360 .019
Financial difficulties 5.6
(Constant) 18.895 2.871 6.582 .000
Rural area 17.468 5.164 3.383 .001
Body image 27.3
(Constant) 44.092 22.231 1.983 .049
University Hospital −25.415 5.139 −4.945 .000
Complications 39.184 10.447 3.751 .000
Mastectomy and reconstruction −12.835 4.566 −2.811 .006
Secondary school −21.429 6.700 −3.198 .002
Rural area −11.661 4.635 −2.516 .013
Sexual function 31.6
(Constant) −8.897 6.750 −1.318 .189
University hospital 25.483 4.445 5.733 .000
Mastectomy without reconstruction −12.415 3.223 −3.852 .000
High school −13.005 4.385 −2.966 .003
Sexual enjoyment 3.8
(Constant) 48.315 2.127 22.719 .000
Mastectomy without reconstruction −8.489 3.008 −2.823 .005
Future perspective 9.1
(Constant) 73.823 12.419 5.944 .000
Mastectomy and reconstruction 15.392 5.441 2.829 .005
Age −.446 .205 −2.172 .031
Secondary school 16.274 7.884 2.064 .040
Systemic therapy side effects 1.7
(Constant) 26.359 2.027 13.007 .000
Urban center −6.133 3.061 −2.003 .047
Breast symptoms 9.1
(Constant) 68.423 15.265 4.482 .000
Athens Metropolitan Area 19.068 3.044 6.264 .000
Complications −22.728 7.273 −3.125 .002
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of the BC women impairs, more adverse economic situa-
tions appear [31]. Further research is needed to investigate
the associations between urban/rural residence and QoL as-
pects in different environments where the concepts of
urbanization and rural life may have different meanings
and impacts. Such studies would help to identify whether
there are disparities in survivors’ support and, if so, to en-
able appropriate and effective development and provision
of health care and supportive care in all areas of the BC
survivors.
Regarding the age, studies showed that older women
with BC have significantly fewer symptoms than younger
women, which is consistent with our findings [32–34].
However, contrary to our findings, an older Greek study
showed that younger patients exhibited better overall
QoL, fewer symptoms, and better functionality than
older [18]. The difference in the results could be inter-
preted in the light that women who suffer the conse-
quences of a serious illness at a relatively young age
have even greater scope to redefine their priorities by
addressing their lives and disease as a challenge to over-
come [18]. The problems that younger women face are
often very different from those encountered by older
ones, such as concerns about early menopause leading
to fertility loss, negative body image [33, 35, 36], sexual-
ity, career, work and financial security [32, 36, 37].
Women with no education or basic education (≤ 12
years at school) reported lower levels in QoL sub-scales,
experiencing more systemic therapy side-effects, more
arm morbidity and reduced physical, cognitive, and emo-
tional function, body image and sexual functioning. This
result is in line with another Greek study that revealed a
statistically significant difference between high education
level and QoL [18]. Similarly, another study states that
women with low education may have jobs that require
more physically demanding work, which leads to delayed
work return, more physical, role, cognitive function, and
financial problems and suggests exercise programs for
faster recovery [12].
On the other hand, a statistically significant finding
revealed that patients with tertiary education reported
better GHS. This can be interpreted by the different per-
spectives these patients adopt for their disease manage-
ment, as the access to information can help them dispel
prejudices [33]. Since young women are frequent users
of social media and often highly educated, maybe the de-
velopment of a multifunction online support hub can
help them find credible and useful information [38]. In
any case, if more concerns arises, they can always ex-
press it to their attending physicians [33].
Besides, the presence of fewer symptoms highlighted
in our study, such as pain and breast/arm morbidity in
older women may be due to their choice of surgical
treatment. A recent research project with results consist-
ent with our study concluded that younger BC women
with reconstruction and more aggressive adjuvant ther-
apies report a more negative body image than those re-
ceiving breast-conserving surgery [39]. The latter can be
seen as a paradox; it can be explained, however, by the
fact that young women who opt for reconstruction are
more conscious of their body and have high, and often
unrealistic, expectations from the breast reconstructive
process [40]. The increased expectations of presumably
younger women undergoing reconstruction may not be
fully met regarding body image. However, they indeed
restore their sexual self-confidence, which may be re-
lated to the image that the social environment shapes
for them. This finding can be positively utilized by BC
Table 3 Summary of Multiple Linear Regression analysis for independent variables predicting sub-scales scores of “QLQ-C30/BR23”
questionnaires (Continued)
Unstandardized Coefficients R2 (%)
B Std. Error t Sig.
Age −.269 .106 −2.539 .012
Arm symptoms 21.8
(Constant) 32.808 8.400 3.905 .000
Athens Metropolitan Area 10.801 3.280 3.293 .001
Sentinel Lymph Node Biopsy −7.558 3.329 −2.270 .024
Age −.335 .111 −3.012 .003
Chemotherapy 9.455 3.244 2.915 .004
No education 12.124 5.194 2.334 .021
Upset by hair loss 9.2
(Constant) 50.282 5.536 9.082 .000
Chemotherapy −14.581 4.103 −3.554 .000
High school 10.011 3.731 2.683 .008
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survivors to regain their confidence and thus their QoL
after treatment.
It is also known that sexuality affects the QoL of women
with BC, as those with an active sexual life report fewer
QoL problems [41]. Our study suggests that women who
had undergone breast reconstruction may maintain a
good overall QoL in sexual function, as we found lower
scores in sexual function and sexual enjoyment in those
with mastectomy without reconstruction. This finding is
consistent with the literature, where reconstruction had
positive effects in this area of QoL [42].
Irrespective of age and the type of surgery for BC sur-
vivors, body image awareness is often associated with
other issues such as social. Therefore, breast loss due to
mastectomy will be perceived by many people as a ser-
ious negative factor in the recognition and sense of self
as a woman. The woman feels something is missing and
may feel sick and disabled. The prevailing social percep-
tion shows the female breasts as a symbol of femininity
and fertility. Women characterize breast loss as a
deprivation of their identity and dignity to the extent
that it even affects the performance of daily activities
[43]. This process is a vicious circle, as harming feminine
identity can affect their overall sense of self, which can,
in turn, negatively affect their body image. However, the
current study showed a positive correlation between
breast reconstruction and future perspective. Many BC
women can accept the fact that they live in a changed
body and maintain a sexual activity and pleasure with
their partners, regardless of the treatments they receive,
even if they had undergone a mastectomy [44].
For those who chose university hospital for their treat-
ment, the GHS and social function were better and
fewer diarrheas were reported, but they lacked body
image, compared to those hospitalized in general hospi-
tals. The comparison between the university and general
hospitals has also been studied in the literature. Studies
focusing on patients hospitalized in university hospitals
record better quality health services, with lower mortal-
ity rates [45, 46]. Hospitals’ affiliation with a university
faculty of medicine provides access to new scientific data
on diagnosis, treatment and rehabilitation. Also, the ex-
istence of more specialized structures in university hos-
pitals increases the patient’s chance of receiving better
health care services.
It is worth mentioning that the Greek law dictates that
all treatment decisions for BC (as well as all types of
cancer) are offered by a multidisciplinary team. Breast
Units are usually organized within a Department of
General Surgery which employees specialized surgeons,
dedicated at least partially, to breast surgery. All hospi-
tals that participated in the study are high volume cen-
ters – including the rural ones – and, although there is
no formal accreditation and no official prerequisites for
Breast Units in Greece, patients involved in the study
had routine full consultations regarding their treatment
and its details, including systemic treatment, radiother-
apy, types of surgery and reconstruction options. Treat-
ment offered to the patients complied with the local and
National guidelines and was consistent across sites.
There is scarce evidence in the literature regarding the
impact of complications on QoL. In their study, Browne
and colleagues found no association between BC compli-
cations and QoL after mastectomy and reconstruction
[47]. In our study, women who reported complications
had better social function, fewer breast symptoms and a
lower score in body image. In their study, Belmonte
et al. [48], found that sentinel lymph node biopsy out-
performs axillary node clearance in terms of QoL, due to
fewer complications from the arm, which is in accord-
ance with the finding of the present study. However, be-
cause of the small sample size (3.5% of the sample had
complications), further studies are needed to confirm
and explain these findings.
Limitations
This study was a cross-sectional and not longitudinal.
Therefore, the changes in QoL over time were not cap-
tured. The sample of the study was not large and only
3.5% of the participants reported complications, so
generalization of the results has to be done with great
caution. Also, the period between the completion of ad-
juvant therapy to participation in the study has not been
recorded. Therefore, patients who may have recently
completed adjuvant therapy may still be under its influ-
ence and therefore report worse QoL. Finally, the study
lacks in considering, according to the participants’ BC
stage and their related knowledge of life expectancy,
their effect on the subjects’ psychological distress and/or
well-being.
Conclusions
Advances of systemic therapies have led to increased
survival rates of BC patients. Despite their important
benefits, these therapies have a series of side effects,
which adversely affect patients’ QoL. Measuring QoL is
considered important, due to the effect it can have on
the patient’s morbidity and mortality.
The present study showed that women with BC have a
satisfactory level of QoL, as they scored high in func-
tionality sub-scales. Regarding the symptoms of the dis-
ease, fatigue, insomnia, financial problems and hair loss
emerged as the most important problems. Age, educa-
tional level and type of hospitalization are statistically re-
lated to the QoL. The emotional function was the least
favorable; hair loss appeared to be the least desirable
side-effect of the treatment. Hair is an integral part of fe-
male identity and has a negative impact on different
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aspects of QoL. Females with non-metastatic BC, with
tertiary education, who were treated in a university hos-
pital, resided in urban areas and had undergone sentinel
lymph node biopsy reported better QoL and fewer
symptoms and complications. The QoL measurement
provides valuable information and reveals those factors
that are crucial for patients’ health status improvement.
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